Theranostic pharmacology in PTSD: Neurobiology and timing
This article will review recent developments in psychopharmacology for PTSD, with a focus on current clinical data that apply putative neurobiologic mechanisms to medication use—i.e., a theranostic approach. A theranostic approach however, also requires consideration of timing, pre, peri or post trauma in conjunction with underlying dynamic processes affecting synaptic plasticity, the HPA axis, hippocampal activation, PFC-amygdala circuitry and fear memory.
Source: Progress in Neuro Psychopharmacology and Biological Psychiatry - Category: Psychiatry Source Type: research
More News: Brain | Cognitive Behavior Therapy | Drugs & Pharmacology | Neurology | Post Traumatic Stress Disorder | Psychiatry | Psychotherapy